Merus Labs International (MSL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MSL.TO | OGI.TO | LOVE.VN | ||
| Company | Merus Labs International | Organigram Holdings Inc | Cannara Biotech Inc | ||
| Price Information | |||||
| Exchange | TSX | TSX | TSX Venture | ||
| Open | 1.64 | 1.93 | 1.840 | ||
| High | 1.65 | 1.95 | 1.890 | ||
| Low | 1.64 | 1.92 | 1.780 | ||
| Latest | 1.65 | 1.93 | 1.890 | ||
| Change | +0.01 | -0.02 | +0.110 | ||
| % Change | +0.61% | -1.03% | +6.18% | ||
| Volume | 21,975 | 21,359 | 63,182 | ||
| 20-Day Average Volume | 164,639 | 281,904 | 55,588 | ||
| Previous Close | 1.64 | 1.95 | 1.780 | ||
| Industry | TSX Drug Specialty & Generic | TSX Drug Specialty & Generic | TSX Drug Specialty & Generic | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.64 | 1.95 | 1.822 | ||
| 20-Day Raw Stochastic | 100.00% | 39.22% | 83.33% | ||
| 20-Day Relative Strength | 68.21 | 43.52 | 55.11 | ||
| Weighted Alpha | -12.80 | +11.39 | +37.76 | ||
| Today's Opinion | N/A | 72% Sell | 96% Buy | ||
| Previous Opinion | N/A | 72% Sell | 56% Buy | ||
| Last Month's Opinion | N/A | 32% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.61% since 07/13/17 | -1.03% since 02/23/26 | +3.28% since 02/20/26 | ||
| Low | 1.64 on 07/20/17 | 1.90 on 02/24/26 | 1.740 on 02/23/26 | ||
| High | 1.65 on 07/20/17 | 2.02 on 02/26/26 | 1.900 on 02/23/26 | ||
| 1-Month | |||||
| %Chg | +1.23% since 06/20/17 | -5.85% since 02/02/26 | +5.59% since 01/27/26 | ||
| Low | 1.62 on 06/21/17 | 1.73 on 02/12/26 | 1.670 on 01/29/26 | ||
| High | 1.65 on 07/20/17 | 2.24 on 02/03/26 | 1.930 on 02/04/26 | ||
| 3-Month | |||||
| %Chg | +60.19% since 04/20/17 | -12.67% since 12/02/25 | +12.50% since 11/27/25 | ||
| Low | 1.01 on 05/10/17 | 1.73 on 02/12/26 | 1.590 on 12/01/25 | ||
| High | 1.65 on 07/20/17 | 3.09 on 12/18/25 | 2.070 on 01/26/26 | ||
| 6-Month | |||||
| %Chg | +55.66% since 01/20/17 | -14.22% since 09/02/25 | +6.18% since 08/27/25 | ||
| Low | 0.96 on 02/03/17 | 1.73 on 02/12/26 | 1.580 on 11/19/25 | ||
| High | 1.65 on 07/20/17 | 3.09 on 12/18/25 | 2.070 on 01/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 192,462 | 263,527 | 181,028 | ||
| Shares Outstanding, K | 117,355 | 135,142 | 95,782 | ||
| Annual Sales | 0 | 259,183,000 | 107,202,535 | ||
| Annual Net Income | 0 | -24,759,000 | 13,076,193 | ||
| Last Quarter Sales | N/A | 63,538,000 | 30,113,175 | ||
| Last Quarter Net Income | N/A | 19,969,000 | 1,039,549 | ||
| 60-Month Beta | 1.86 | 1.97 | -0.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 | 0.15 on 02/10/26 | 0.01 on 01/26/26 | ||
| Latest Earnings Date | 03/25/26 | 02/10/26 | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | 12.66 | 15.75 | ||